|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-8-21
|
|
pubmed:abstractText |
Deletions or structural abnormalities in chromosomes 11 and 13 have been shown to be important in predicting clinical behavior in patients with multiple myeloma (MM). However, cytogenetic analysis in MM is frequently difficult because of poor yield of informative metaphases and the disease is frequently patchy, which complicates fluorescent in situ hybridization studies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0902-4441
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
174-8
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12930317-Adult,
pubmed-meshheading:12930317-Aged,
pubmed-meshheading:12930317-Aged, 80 and over,
pubmed-meshheading:12930317-Chromosomes, Human, Pair 11,
pubmed-meshheading:12930317-Chromosomes, Human, Pair 13,
pubmed-meshheading:12930317-DNA,
pubmed-meshheading:12930317-Gene Deletion,
pubmed-meshheading:12930317-Heterozygote,
pubmed-meshheading:12930317-Humans,
pubmed-meshheading:12930317-Loss of Heterozygosity,
pubmed-meshheading:12930317-Microsatellite Repeats,
pubmed-meshheading:12930317-Middle Aged,
pubmed-meshheading:12930317-Multiple Myeloma,
pubmed-meshheading:12930317-Polymerase Chain Reaction,
pubmed-meshheading:12930317-Prognosis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma.
|
|
pubmed:affiliation |
Department of Hematopathology, M.D. Anderson Cancer Center, The University of Texas, Houston, TX 77030-4095, USA.
|
|
pubmed:publicationType |
Journal Article
|
